Search results

Filter (6 in use)

Area of interest

Type

Status

Last updated

Guidance programme 6 selected

620 results

Relevance Date

  4. Inducing labour (update)

    In development [GID-NG10082] Expected publication date: 14 October 2021

    NICE guideline
    In development

  10. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 09 June 2021

    NICE guideline
    In development

  11. Caesarean section (update)

    In development [GID-NG10081] Expected publication date: 31 March 2021

    NICE guideline
    In development

  25. Postnatal care

    In development [GID-NG10070] Expected publication date: 07 April 2021

    NICE guideline
    In development

  27. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

    NICE guideline
    In development

  28. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 23 March 2023

    NICE guideline
    In development

  32. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

    NICE guideline
    In development

  33. Antenatal care

    In development [GID-NG10096] Expected publication date: 11 August 2021

    NICE guideline
    In development

  42. Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)

    Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are

    Diagnostics guidance
    Published
    View recommendations

  45. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I (DG32)

    Evidence-based recommendations on 2 adjunctive colposcopy technologies (the DYSIS colposcope with DYSISmap and the ZedScan I) for assessing suspected cervical

    Diagnostics guidance
    Published
    View recommendations

  46. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the

    Diagnostics guidance
    Published
    View recommendations

  47. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (DG34)

    Evidence-based recommendations on tumour profiling tests to guide adjuvant chemotherapy decisions for people with early breast cancer. The tests are EndoPredict

    Diagnostics guidance
    Published
    View recommendations

  48. SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver (DG5)

    Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver

    Diagnostics guidance
    Published
    View recommendations

  49. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75selenium] acid) for diagnosing bile acid malabsorption in people with IBS-D or Crohn’s disease

    Diagnostics guidance
    Published
    View recommendations

  50. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29)

    Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis

    Diagnostics guidance
    Published
    View recommendations